Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Good news in the nuclear envelope: loss of lamin A might be a gain
Paola Scaffidi, Tom Misteli
Paola Scaffidi, Tom Misteli
Published March 1, 2006
Citation Information: J Clin Invest. 2006;116(3):632-634. https://doi.org/10.1172/JCI27820.
View: Text | PDF
Commentary

Good news in the nuclear envelope: loss of lamin A might be a gain

  • Text
  • PDF
Abstract

Genetic diseases often reveal the physiological roles of the affected proteins. The identification of mutations in the nuclear envelope proteins lamin A and lamin C as the cause of a diverse group of human diseases has expanded our understanding of the lamin proteins from being merely structural elements of the cell nucleus and has implicated them in novel cellular functions including signal transduction and gene expression. However, it now appears that the physiological relevance of one of the lamin proteins in organismal function has been overestimated. In this issue of the JCI, Fong et al. demonstrate that lamin A–deficient mice are phenotypically normal (see the related article beginning on page 743). The good news is these findings open the door to a new strategy for the therapeutic treatment of diseases caused by mutations in lamin A, such as muscular dystrophies and some types of premature aging syndromes.

Authors

Paola Scaffidi, Tom Misteli

×

Total citations by year

Year: 2024 2022 2020 2019 2016 2014 2013 2011 2008 Total
Citations: 1 1 1 1 1 1 1 1 1 9
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (9)

Title and authors Publication Year
Navigating Lipodystrophy: Insights from Laminopathies and Beyond
Krüger P, Hartinger R, Djabali K
International journal of molecular sciences 2024
Breaking the aging epigenetic barrier
Sikder S, Arunkumar G, Melters DP, Dalal Y
Frontiers in Cell and Developmental Biology 2022
Lamin microaggregates lead to altered mechanotransmission in progerin-expressing cells
Danielsson BE, Tieu KV, Bathula K, Armiger TJ, Vellala PS, Taylor RE, Dahl KN, Conway DE
Nucleus 2020
Hutchinson-Gilford Progeria Syndrome—Current Status and Prospects for Gene Therapy Treatment
K Piekarowicz, M Machowska, V Dzianisava, R Rzepecki
Cells 2019
Cell Mechanosensitivity Is Enabled by the LINC Nuclear Complex
G Uzer, CT Rubin, J Rubin
Current Molecular Biology Reports 2016
Prelamin A accumulation and stress conditions induce impaired Oct-1 activity and autophagy in prematurely aged human mesenchymal stem cell.
Infante A, Gago A, de Eguino GR, Calvo-Fernández T, Gómez-Vallejo V, Llop J, Schlangen K, Fullaondo A, Aransay AM, Martín A, Rodríguez CI
Aging 2014
SCFSlimb ubiquitin ligase suppresses condensin II–mediated nuclear reorganization by degrading Cap-H2
Buster DW, Daniel SG, Nguyen HQ, Windler SL, Skwarek LC, Peterson M, Roberts M, Meserve JH, Hartl T, Klebba JE, Bilder D, Bosco G, Rogers GC
The Journal of Cell Biology 2013
Progerin and telomere dysfunction collaborate to trigger cellular senescence in human fibroblast cells
Kan Cao, Cecilia Blair, Dina Faddah, Julia Kieckhaefer, Michelle Olive, Michael Erdos, Elizabeth Nabel, Francis Collins
Journal of Clinical Investigation 2011
Progerin, the Protein Causing Hutchinson-Gilford Progeria Syndrome, Elicits Disease Whether or Not It Is Farnesylated
Shao H. Yang, Douglas A. Andres, H. Peter Spielmann, Stephen G. Young, and Loren G. Fong
Journal of Clinical Investigation 2008

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts